Parkinson's disease: A dual-hit hypothesis

Neuropathology and Applied Neurobiology

Volumn 33, Issue 6, 2007, Pages 599-614

  Hawkes, C H ^a   Del Tredici, K ^b   Braak, H ^b  

^a QUEEN S HOSPITAL   (United Kingdom)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Aetiology; Autonomic regulation; Olfaction; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN;

CHOLINERGIC TRANSMISSION; DISEASE COURSE; GASTROINTESTINAL DISEASE; HEART DISEASE; HUMAN; MEDULLA OBLONGATA; MESENCEPHALON; MOTONEURON; NEUROPHYSIOLOGY; NOSE SECRETION; PARASYMPATHETIC GANGLION; PARASYMPATHETIC NERVE CELL; PARKINSON DISEASE; PATHOGENESIS; PONS; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; REVIEW; SLEEP DISORDER; SMELLING; STOMACH; SUBSTANTIA NIGRA; SWALLOWING; TEMPORAL LOBE; VAGUS NERVE; VIRUS; VIRUS INFECTION;

ANIMALS; GASTROINTESTINAL DISEASES; HEART DISEASES; HUMANS; MODELS, NEUROLOGICAL; OLFACTION DISORDERS; PARKINSON DISEASE; SLEEP DISORDERS; VIRUS DISEASES;

EID: 35949004474     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2007.00874.x     Document Type: Review

References (157)

1. Hague K, Lento P, Morgello S, Caro S, Kaufmann H. The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature. Acta Neuropathol 1997 94 : 92 6
2. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson's disease. Arch Neurol 1999 56 : 33 9
3. Jellinger KA. Neuropathological spectrum of synucleinopathies. Mov Disord 2003 18 (Suppl. 6 2 12
4. Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I. SIC Task force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003 18 : 467 86
5. Geser F, Wenning GK, Poewe W, McKeith I. How to diagnose dementia with Lewy bodies: state of the art. Mov Disord 2005 20 (Suppl. 12 11 20
6. Lowe J. Lewy bodies. In Neurodegenerative Diseases. DP Calne. Philadelphia, PA : Saunders, 1994 51 69
7. Duda JE, Lee VMY, Trojanowski JQ. Neuropathology of synuclein aggregates: new insights into mechanism of neurodegenerative diseases. J Neurosci Res 2000 61 : 121 7
8. Del Tredici K, Braak H. Idiopathic Parkinson's disease: staging an α-synucleinopathy with a predictable pathoanatomy. In Molecular Mechanisms in Parkinson's Disease. P Kahle, C Haass. Georgetown, TX : Landes Bioscience, 2004 1 32
9. Jellinger K. Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. Mol Chem Neuropathol 1991 14 : 153 97
10. Takahashi H, Wakabayashi K. The cellular pathology of Parkinson's disease. Neuropathology 2001 21 : 315 22
11. Takahashi H, Wakabayashi K. Controversy: is Parkinson's disease a single disease entity? Yes. Parkinsonism Relat Disord 2005 11 : 31 7
12. Braak H, Del Tredici K. Preclinical and clinical stages of intracerebral inclusion body pathology in idiopathic Parkinson's disease. In Parkinson's Disease: Progress in Research. Ed. JM Willow. Hauppauge, NY : Nova Science, 2005 1 49
13. Braak H, Del Tredici K. Poor and protracted myelination as a contributory factor to neurodegenerative disorders. Neurobiol Aging 2004 25 : 19 23
14. Thal DR, Del Tredici K, Braak H. Neurodegeneration in normal brain aging and disease. Sci Aging Knowledge Environ 2004 23 : 1 13
15. Mikolaenko I, Pletnikova O, Kawas CH, O'Brien R, Resnick SM, Crain B, Troncosco JC. Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore Longitudinal Study of Aging (BLSA). J Neuropathol Exp Neurol 2005 64 : 156 62
16. Foley P, Riederer P. Pathogenesis and preclinical course of Parkinson's disease. J Neural Transm Suppl 1999 56 : 31 74
17. Wolters EC, Francot C, Bergmans P, Winogrodzka A, Booij J, Berendse HW, Stoof JC. Preclinical premotor; Parkinson's disease. J Neurol 2000 247 (Suppl. 2 103 9
18. Przuntek H, Müller T, Riederer P. Diagnostic staging of Parkinson's disease: conceptual aspects. J Neural Transm 2004 111 : 201 16
19. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988 51 : 745 52
20. Hawkes CH, Shephard BC, Daniel SE. Is Parkinson's disease a primary olfactory disorder? Q J Med 1999 92 : 473 80
21. Del Tredici K, Rüb U, de Vos RAI, Bohl JRE, Braak H. Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 2002 61 : 413 26
22. Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003 24 : 197 211
23. Braak H, Rüb U, Del Tredici K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 2003 110 : 517 36
24. Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004 318 : 121 34
25. Braak H, Müller CM, Rüb U, Ackermann H, Bratzke H, de Vos RAI, Del Tredici K. Pathology associated with sporadic Parkinson's disease - where does it end? J Neural Transm Suppl 2006 70 : 89 97
26. Lang AE, Obeso JA. Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol 2004 3 : 309 16
27. Ahlskog JE. Challenging conventional wisdom: the etiologic role of dopamine oxidative stress in Parkinson's disease. Mov Disord 2005 20 : 271 82
28. Langston JW. The Parkinson's complex: Parkinsonism is just the tip of the iceberg. Ann Neurol 2006 59 : 591 6
29. Ansari KA, Johnson A. Olfactory function in patients with Parkinson's disease. J Chronic Dis 1975 28 : 493 7
30. Quinn NP, Rossor MN, Marsden CD. Olfactory threshold in Parkinson's disease. J Neurol Neurosurg Psychiatry 1987 50 : 88 9
31. Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 1988 38 : 1237 44
32. Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1992 55 : 138 42
33. Hawkes CH, Shephard BC, Daniel SE. Olfactory dysfunction in Parkinson's disease. J Neurol Neurosurg Psychiatry 1997 62 : 436 46
34. Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G. 'Sniffin sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 1997 22 : 39 52
35. Daum RF, Sekinger B, Kobal G, Lang CJ. Olfactory testing with 'sniffin' sticks' for clinical diagnosis of Parkinson's disease. Nervenarzt 2000 71 : 643 50
36. Liberini P, Parola S, Spano PF, Antonini I. Olfaction in Parkinson's disease: methods of assessment and clinical relevance. J Neurol 2000 247 : 88 96
37. Hawkes CH. Olfaction in neurodegenerative disorder. Mov Disord 2003 18 : 364 72
38. Doty RL. Olfaction. Annu Rev Psychol 2001 52 : 423 52
39. Katzenschlager R, Lees AJ. Olfaction and Parkinson's syndromes: its role in differential diagnosis. Curr Opin Neurol 2004 17 : 417 23
40. Kobal G, Plattig KH. Objective olfactometry: methodological annotations for recording olfactory EEG-responses from the awake human. EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb 1978 9 : 135 45
41. Barz S, Hummel T, Pauli E, Majer M, Lang CJ, Kobal G. Chemosensory event-related potentials in response to trigeminal and olfactory stimulation in idiopathic Parkinson's disease. Neurology 1997 49 : 1424 31
42. Tissingh G, Berendse HW, Bergmanns P, De Waard R, Drukarch B, Stoof JC, Wolters EC. Loss of olfaction in de novo and treated Parkinson's disease: possible implication for early diagnosis. Mov Disord 2001 16 : 41 6
43. Montgomery EB Jr, Baker KB, Lyons K, Koller WC. Abnormal performance on the PD test battery by asymptomatic first-degree relatives. Neurology 1999 52 : 757 62
44. Montgomery EB Jr, Lyons K, Koller WC. Early detection of probable idiopathic Parkinson's disease: II. A prospective application of a diagnostic test battery. Mov Disord 2000 15 : 474 8
45. Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters EC, Berendse HW. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 2004 56 : 173 81
46. Sommer U, Hummel T, Cormann K, Mueller A, Frasnelli J, Kropp J, Reichmann H. Detection of presymptomatic Parkinson's disease. combining smell tests transcranial sonography and SPECT. Mov Disord 2004 19 : 1196 202
47. Ross W, Petrovitch H, Abbott RD, Tanner CM, Popper Masaki K. Association of olfactory dysfunction with risk of future Parkinson's disease. Mov Disord 2005 20 (Suppl. 10 439
48. Doty RL, Marcus A, Lee WW. Development of the 12-item cross-cultural smell identification test CC-SIT. Laryngoscope 1996 106 : 353 6
49. Ross GW, Abbott RD, Petrovitch H, Tanner CM, Davis DG, Nelson J, Markesbery WR, Hardman J, Masaki K, Launer L, White LR. Association of olfactory dysfunction with incidental Lewy bodies. Mov Disord 2006 21 : 2062 7
50. Marras C, Goldman S, Smith A, Barney P, Aston D, Comyns K, Korell M, Langston JW, Ross GW, Tanner CM. Smell identification ability in twin pairs discordant for Parkinson's disease. Mov Disord 2005 20 : 687 93
51. Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 2001 57 : 1497 9
52. Jost WH. Autonomic dysfunctions in idiopathic Parkinson's disease. J Neurol 2003 250 (Suppl. 1 28 30
53. Micieli G, Tosi P, Marcheselli S, Cavallini A. Autonomic dysfunction in Parkinson's disease. Neurol Sci 2003 24 : 32 4
54. Visser M, Marinus J, Stiggelbout AM, van Hilten J. Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT. Mov Disord 2004 19 : 1306 12
55. Goetze O, Wieczorek J, Mueller T, Przuntek H, Schmidt WE, Woitalla D. Impaired gastric emptying of a solid test meal in patients with Parkinson's disease using 13C-sodium octanoate breadth test. Neurosci Lett 2005 375 : 170 3
56. Bine JE, Frank EM, McDade HL. Dysphagia and dementia in subjects with Parkinson's disease. Dysphagia 1995 10 : 160 4
57. Muller J, Wenning GK, Verny M, McKee A, Chaudhuri KR, Jellinger K. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol 2001 58 : 259 64
58. Hawkes CH. Smell and Taste Complaints. Boston, MA : Butterworth- Heinemann/Elsevier, 2002
59. Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol 2003 2 : 107 16
60. Tumilasci OR, Cersosimo MG, Belforte JE, Micheli FE, Benarroch EE, Pazo JH. Quantitative study of salivary secretion in Parkinson's disease. Mov Disord 2006 21 : 660 7
61. Edwards LL, Quigley EM, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease: frequency and pathophysiology. Neurology 1992 42 : 726 32
62. Hardoff R, Sula M, Tamir A, Soil A, Front A, Badarna S. Gastric emptying time and gastric motility in patients with Parkinson's disease. Mov Disord 2001 16 : 1041 7
63. Sulla M, Hardoff R, Giladi N. Gastric emptying time and gastric motility in patients with untreated Parkinson's disease. Mov Disord 1996 11 : 1041 7
64. Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, Grandinetti A, Blanchette PL, Popper JS, Ross GW. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001 57 : 456 62
65. Siddiqui MF, Rast S, Lynn MJ, Auchus AP, Pfeiffer RF. Autonomic dysfunction in Parkinson's disease: a comprehensive symptom survey. Parkinsonism Relat Disord 2002 8 : 277 84
66. Jost WH, Jung G, Schimrigk K. Colonic transit time in non-idiopathic Parkinson's syndrome. Eur Neurol 1994 34 : 329 31
67. Jost WH, Schrank B. Defecatory disorders in de novo Parkinsonians - colonic transit and electromyogram of the external anal sphincter. Wien Klin Wochenschr 1998 110 : 535 7
68. 123I-MIBG uptake in Parkinson's disease. Acta Neurol Scand 1998 97 : 303 6
69. 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value. J Nucl Med 1999 40 : 371 5
70. Goldstein DS, Holmes C, Li ST, Bruce S, Metman LV, Cannon RO. Cardiac sympathetic denervation in Parkinson's disease. Ann Intern Med 2000 133 : 338 47
71. Takatsu H, Nishida H, Matsuo H, Watanabe S, Nagashima K, Wada H, Noda T, Nishigaki K, Fujiwara H. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG. J Nucl Med 2000 41 : 71 7
72. Taki J, Yoshita M, Yamada M, Tonami N. Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body disease. Ann Nucl Med 2004 18 : 453 61
73. Haapaniemi TH, Pursiainen V, Korpelainen JT, Huikuri HV, Sotaniemi KA, Myllyla VV. Ambulatory ECG and analysis of heart rate variability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2001 70 : 305 10
74. Iwanaga K, Wakabayashi K, Yoshimoto M, Tomita I, Satoh H, Takashima H. Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases. Neurology 1999 52 : 1269 71
75. Orimo S, Amino T, Itoh Y, Takahashi A, Kojo T, Uchihara T, Tsuchiya K, Mori F, Wakabayashi K, Takahashi H. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathol (Berl) 2005 109 : 583 8
76. Kaufmann H, Nahm K, Purohit D, Wolfe D. Autonomic failure as the initial manifestation of Parkinson's disease and dementia with Lewy bodies. Neurology 2004 63 : 1093 5
77. Lee PH, Yeo SH, Kim HJ, Youm HY. Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy. Mov Disord 2006 21 : 1975 7
78. Adler CH, Thorpy MJ. Sleep issues in Parkinson's disease. Neurology 2005 64 (Suppl. 3 12 20
79. Schenck CH, Bundlie SR, Mahowald MW. REM behavior disorder (RBD), delayed emergence of parkinsonism and/or dementia in 65% of older men initially diagnosed with idiopathic RBD, and an analysis of the minimum & maximum tonic and/or phasic electromyographic abnormalities found during REM sleep. Sleep 2003 26 (Suppl. 316 [Abs 0794.M; A316]
80. Boeve BF, Silber MH, Saper CB, Ferman TJ, Dickson DW, Parisi JE, Benarroch EE, Ahlskog JE, Smith GE, Caselli RC, Tippman-Peikert M, Olson EJ, Lin SC, Young T, Wszolek Z, Schenck CH, Mahowald MW, Castillo PR, Del Tredici K, Braak H. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 2007 doi: 10.1093/brain/awm056
81. Abbott RD, Ross GW, White LR, Tanner CM, Masaki KH, Nelson JS, Curb JD, Petrovitch H. Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology 2005 65 : 1442 6
82. Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 1996 46 : 388 93
83. Eisensehr I, Linke R, Tatsch K, Kharraz B, Gildehaus JF, Wetter CT, Trenkwalder C, Schwarz J, Noachtar S. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls. Sleep 2003 26 : 507 12
84. Stiasny-Kolster K, Doerr Y, Möller JC, Hoffken H, Behr TM, Oertel WH, Mayer G. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for α-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 2005 128 : 126 37
85. Postuma RB, Lang AE, Massicotte-Marquez J, Montplaisir J. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 2006 66 : 845 51
86. Fantini ML, Postuma RB, Montplaisir J, Ferini-Strambi L. Olfactory deficit in idiopathic rapid eye movements sleep behavior disorder. Brain Res Bull 2006 70 : 386 90
87. Iranzo A, Santamaria J, Rye DB, Valldeoriola F, Marti MJ, Munoz E. Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD. Neurology 2005 65 : 247 52
88. Braak H, de Vos RAI, Bohl J, Del Tredici K. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett 2006 396 : 67 72
89. Braak H, Sastre M, Bohl JRE, de Vos RAI, Del Tredici K. Parkinson's disease: Lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol 2007 113 : 421 9
90. Braak H, Braak E, Yilmazer D, de Vos RA, Jansen ENH, Bohl J, Jellinger K. Amygdala pathology in Parkinson's disease. Acta Neuropathol 1994 88 : 493 500
91. Bohus B, Koolhaas JM, Luiten PGM, Korte SM, Roozendaal B, Wiersma A. The neurobiology of the central nucleus of the amygdala in relation to neuroendocrine and autonomic outflow. Prog Brain Res 1996 107 : 447 60
92. Liubashima O, Jolkkonen E, Pitkänen A. Projections from the central nucleus of the amygdala to the gastric related area of the dorsal vagal complex: a Phaseolus vulgaris leucoagglutinin study in rat. Neurosci Lett 2000 291 : 85 8
93. Zhang X, Cui J, Tan Z, Jiang C, Fogel R. The central nucleus of the amygdala modulates gut-related neurons in the dorsal vagal complex in rats. J Physiol 2003 553 : 1005 18
94. Parkkinen L, Kauppinen T, Pirttila T, Autere JM, Alafuzoff I. α-Synuclein pathology does not predict extrapyramidal symptoms or dementia. Ann Neurol 2005 57 : 82 91
95. Jellinger KA. Lewy body-related alpha-synucleinopathy in the aged human brain. J Neural Transm 2004 111 : 1219 35
96. Neumann M, Müller V, Kretzschmar HA, Haass C, Kahle PJ. Regional distribution of proteinase-K-resistent α-synuclein correlates with Lewy body disease stage. Neuropathol Exp Neurol 2004 63 : 1225 35
97. Saito Y, Ruberu NN, Sawabe M, Arai T, Kazama H, Hosoi T, Yamanouchi H, Murayami S. Lewy body-related alpha-synucleinopathy in aging. J Neuropathol Exp Neurol 2004 63 : 742 9
98. Uchikado H, Lin WL, DeLucia MW, Dickson DW. Alzheimer disease with amgydala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 2006 65 : 685 97
99. Müller CM, de Vos RAI, Maurage CA, Thal DR, Tolnay M, Braak H. Staging of sporadic Parkinson disease-related alpha-synuclein pathology: inter- and intra-rater reliability. J Neuropathol Exp Neurol 2005 64 : 623 8
100. Duda JE, Shah U, Arnold SE, Lee VM, Trojanowski JQ. The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases. Exp Neurol 1999 160 : 515 22
101. Witt M, Gudziol V, Haehner A, Reichmann H, Hummel T. Nasal mucosa in patients with Parkinson's disease. Chem Senses 2006 31 : 479 93 (Abstract 106)
102. Daniel SE, Hawkes CH. Preliminary diagnosis of Parkinson's disease by olfactory bulb pathology. Lancet 1992 340 : 186
103. Pearce RK, Hawkes CH, Daniel SE. The anterior olfactory nucleus in Parkinson's disease. Mov Disord 1995 10 : 283 7
104. Huisman E, Uylings HB, Hoogland PV. A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease. Mov Disord 2004 19 : 687 92
105. Price JL. Olfaction. In The Human Nervous System, 2nd edn. Eds G Paxinos, JM Mai. San Diego, CA : Elsevier Academic Press, 2004 1198 212
106. Jager W, den Hartog WA, Bethlem J. The distribution of Lewy bodies in the central and autonomic nervous system in idiopathic paralysis agitans. J Neurol Neurosurg Psychiatry 1960 23 : 283 90
107. Qualman SJ, Haupt HM, Yang P, Hamilton SR. Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease. Gastroenterol 1984 87 : 848 56
108. Wakabayashi K, Takahashi H. Neuropathology of autonomic nervous system in Parkinson's disease. Eur Neurol 1997b 38 (Suppl. 2 2 7
109. Wakabayashi K, Takahashi H, Ohama E, Ikuta F. Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol 1990 79 : 581 3
110. Wakabayashi K, Takahashi H, Ohama E, Takeda S, Ikuta F. Lewy bodies in the visceral autonomic nervous system in Parkinson's disease. Adv Neurol 1993 60 : 609 12
111. Costa M, Brookes SJH, Hennig GW. Anatomy and physiology of the enteric nervous system. Gut 2000 47 (Suppl. 4 iv15 19
112. Furness JB. Types of neurons in the enteric nervous system. J Auton Nerv Syst 2000 81 : 87 96
113. Anlauf M, Schäfer MKH, Eiden L, Weihe E. Chemical coding of the human gastrointestinal nervous system: cholinergic, VIPergic, and catecholaminergic phenotypes. J Comp Neurol 2003 459 : 90 111
114. Huang XF, Törk I, Paxinos G. Dorsal motor nucleus of the vagus nerve: a cyto- and chemoarchitectonic study in the human. J Comp Neurol 1993 330 : 158 82
115. Hopkins DA, Bieger D, de Vente J, Steinbusch HWM. Vagal efferent projections: viscerotopy, neurochemistry and effects of vagotomy. Prog Brain Res 1996 107 : 79 96
116. Huang XF, Paxinos G. Human intermediate reticular zone: a cyto- and chemoarchitectonic study. J Comp Neurol 1995, 2004 360 : 571 88
117. Blessing WW. Lower brain stem regulation of visceral, cardiovascular, and respiratory function. In The Human Nervous System, 2nd edn. Eds G Paxinos, JK Mai San Diego, CA : Elsevier Academic Press, 2004 464 78
118. Wakabayashi K, Takahashi H. The intermediolateral nucleus and Clarke's column in Parkinson's disease. Acta Neuropathol 1997a 94 : 287 9
119. Bloch A, Probst A, Bissig H, Adams H, Tolnay M. α-Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol Appl Neurobiol 2006 12 : 284 95
120. Klos KJ, Ahlskog JE, Josephs KA, Apaydin H, Parisi JE, Boeve BF. Alpha-synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals. Neurology 2006 66 : 1100 2
121. Pearson RCA, Esiri MM, Hiorns RW, Wilcock GK, Powell TPS. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer's disease. Proc Natl Acad Sci USA 1985 82 : 4531 4
122. Saper CB, Wainer BH, German DC. Axonal and transneuronal transport in the transmission of neurological disease: potential role in system degenerations, including Alzheimer's disease. Neuroscience 1987 23 : 389 98
123. Kristensson K. Sorting signals and targeting of infectious agents through axons: an annotation to the 100 years' birth of the name 'axon'. Brain Res Bull 1996 41 : 327 33
124. Pearson RCA. Cortical connections and the pathology of Alzheimer's disease. Neurodegeneration 1996 5 : 429 34
125. Card JP. Exploring brain circuitry with neurotropic viruses: new horizons in neuroanatomy. Anat Rec 1998 253 : 176 85
126. Mufson EJ, Kroin JS, Sendera TJ, Sobreviela T. Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases. Prog Neurobiol 1999 57 : 451 84
127. Rinaman L, Levitt P, Card JP. Progressive postnatal assembly of limbic-autonomic circuits revealed by central transneuronal transport of pseudorabies virus. J Neurosci 2000 20 : 2731 41
128. Nicotera P. A route for prion neuroinvasion. Neuron 2001 31 : 345 8
129. Hill TJ. Ocular pathogenicity of herpes simplex virus. Curr Eye Res 1987 6 : 1 7
130. Morrison LA, Sidman RL, Fields BN. Direct spread of reovirus from the intestinal lumen to the central nervous system through vagal autonomic nerve fibers. Proc Natl Acad Sci USA 1991 88 : 3852 6
131. Enquist LW, Card JP. Recent advances in the use of neurotropic viruses for circuit analysis. Curr Opin Neurobiol 2003 13 : 603 6
132. Matsuda K, Park CH, Synden Y, Kimura T, Ochiai K, Kida H. The vagus nerve is one route of transneural invasion for intranasally inoculated influenza A virus in mice. Vet Pathol 2004 41 : 101 7
133. Broadwell RD, Brightman MV. Entry of peroxidase into neurons of the central and peripheral nervous systems from extracerebral and cerebral blood. J Comp Neurol 1976 166 : 257 84
134. Elizan TS, Casals J. The viral hypothesis in parkinsonism. J Neural Transm Suppl 1983 19 : 75 88
135. Ahlskog JE, Waring SC, Petersen RC, Esteban-Santillan C, Craig UK, O'Brien PC, Plevak MF, Kurland LT. Olfactory dysfunction in Guamanian ALS, parkinsonism, and dementia. Neurology 1998 51 : 1672 7
136. Takahashi M, Yamada T. A possible role of influenza A virus infection for Parkinson's disease. Adv Neurol 2001 86 : 91 104
137. Gamboa ET, Wolf A, Yahr MD, Harter DH, Duffy PE, Barden H, Hsu KC. Influenza virus antigen in postencephalitic parkinsonism brain. Arch Neurol 1974 31 : 228 32
138. Marttila RJ, Halonen P, Rinne UK. Influenza virus antibodies in Parkinsonism. Comparison of postencephalic and idiopathic Parkinson patients and matched controls. Arch Neurol 1977 34 : 99 100
139. Elizan TS, Madden DL, Noble GR, Herrmann KL, Gardner J, Schwartz J, Smith H, Sever JL, Yahr MD. Viral antibodies in serum and CSF of parkinsonian patients and controls. Arch Neurol 1979 36 : 529 34
140. Schwartz J, Elizan TS. Search for viral particles and virus-specific products in idiopathic Parkinson disease brain material. Ann Neurol 1979 6 : 261 3
141. Wetmur JG, Schwartz J, Elizan TS. Nucleic acid homology studies of viral nucleic acids in idiopathic Parkinson's disease. Arch Neurol 1979 36 : 462 4
142. Solbrig MV, Nashef L. Acute parkinsonism in suspected herpes simplex encephalitis. Mov Disord 1993 8 : 233 4
143. Howard JS. Tic douloureux, Parkinson's disease and the herpes connection. Integr Physiol Behav Sci 1997 32 : 257 64
144. Marttila RJ, Rinne UK, Halonen P, Madden DL, Sever JL. Herpesviruses and Parkinsonism. Herpes simplex virus types 1 and 2, and cytomegalovirus antibodies in serum and CSF. Arch Neurol 1981 38 : 19 21
145. Marttila RJ, Rinne UK, Tilikainen A. Virus antibodies in Parkinson's disease. J Neurol Sci 1982 54 : 227 38
146. Fazzini E, Fleming J, Fahn S. Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease. Mov Disord 1992 7 : 153 8
147. Bower JH, Maraganore DM, Peterson BJ, Ahlskog JE, Rocca WA. Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: a case-control study. Neurology 2006 67 : 494 6
148. Klimek L. Sense of smell in allergic rhinitis. Pneumologie 1998 52 : 196 202
149. Masucci MG. Epstein-Barr virus oncogenesis and the ubiquitin-proteasome system. Oncogene 2004 23 : 2107 15
150. Shackelford J, Pagano JS. Targeting of host-cell ubiquitin pathways by viruses. Essays Biochem 2005 41 : 139 56
151. Tomlinson AH, Esiri MM. Herpes simplex encephalitis: immuno-histological demonstration of spread of virus via olfactory pathways in mice. J Neurol Sci 1983 60 : 473 84
152. Shipley MT. Transport of molecules from nose to brain: transneuronal anterograde and retrograde labelling in the rat olfactory system by wheatgerm agglutin-horseradish peroxidase applied to the nasal epithelium. Brain Res Bull 1985 15 : 129 42
153. Newman R, Winans SS. An experimental study of the ventral striatum of the golden hamster. II. Neuronal connections of the olfactory tubercle. J Comp Neurol 1980 191 : 193 212
154. Blessing WW, Li YW, Wesselingh SL. Transneuronal transport of herpes simplex virus from the cervical vagus to brain neurons with axonal inputs to central vagal sensory nuclei in the rat. Neuroscience 1991 42 : 261 74
155. Park CH, Ishinaka M, Takada A, Kida H, Kimura T, Ochiai K, Umimura T. The invasion routes of neurovirulent A/Hong Kong/483/97, H5N1; influenza virus into the central nervous system after respiratory infection in mice. Arch Virol 2002 147 : 1425 36
156. Shinya K, Shimada A, Ito T, Otsuki K, Morita T, Tanaka H, Takada A, Kida H, Umemura T. Avian influenza virus intranasally inoculated infects the central nervous system of mice through the general visceral afferent nerve. Arch Virol 2000 145 : 187 95
157. Halliday G, Del Tredici K, Braak H. Critical appraisal of the Braak staging of brain. pathology related to sporadic Parkinson's disease. J Neural Transm (Suppl) 2006 70 : 99 103